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Abstract: Zinc chloride has the importance in pharmaceutical/nutraceutical industries for the prevention and treatment of 
several diseases. The objective of the current study was to investigate the impact of The Trivedi Effect®-Energy of 
Consciousness Healing Treatment (Biofield Energy Healing Treatment) on physical, structural, and thermal properties of zinc 
chloride using PXRD, PSD, FT-IR, UV-vis, TGA, and DSC analysis. Zinc chloride was divided into two parts. One part was 
denoted as the control without any, while the other part was defined as the Trivedi Effect® Treated sample, which received the 
Trivedi Effect® Treatment remotely from eighteen renowned Biofield Energy Healers. The PXRD analysis revealed that the 
crystallite size and relative intensities of the PXRD peaks significantly altered in the treated sample compared with the control 
sample. The crystallite size of treated sample was decreased by 4.19% compared with the control sample. The particle size at 
d10 and d50 of the Biofield Energy Treated sample decreased by 4.72% and 2.70%, respectively compared with the control 
sample. But, the particle size of the treated sample increased at d90 by 0.83 compared with the control sample. Consequently, 
the surface area was increased by 3.22% in the treated sample compared with the control sample. The FT-IR spectroscopic 
analysis revealed that Zn-Cl stretching in the control and treated sample was at 520 cm-1 and 521 cm-1, respectively. The UV-
vis analysis exhibited that the wavelength of the maximum absorbance of the control and treated samples was at 196.4 and 
196.2 nm, respectively. The TGA thermograms revealed two steps of the thermal degradation and the weight loss of the treated 
sample was significantly reduced by 22.54% in the 1st step of degradation compared with the control sample. The DSC 
analysis showed that the enthalpy of decomposition was significantly increased by 34.9% in the treated sample (89.17 J/g) 
compared with the control sample (66.10 J/g). Overall, DSC and TGA analysis indicated that the thermal stability of the 
treated sample was increased compared with the control sample. The current study anticipated that The Trivedi Effect®-Energy 
of Consciousness Healing Treatment might lead to generate a new polymorphic form of zinc chloride, which would be more 
soluble, stable, and higher absorption rate compared with the control sample. Hence, the treated zinc chloride could be very 
useful to design the various forms of nutraceuticals and pharmaceutical formulation which might be providing a better 
12 Mahendra Kumar Trivedi et al.:  Evaluation of the Trivedi Effect®- Energy of Consciousness Energy Healing   
Treatment on the Physical, Spectral, and Thermal Properties of Zinc Chloride 
therapeutic response against inflammatory diseases, immunological disorders, aging, stress, cancer, etc. 
Keywords: Energy of Consciousness Healing Treatment, Biofield Energy Healing Treatment, Biofield Energy Healers,  
The Trivedi Effect®, Zinc Chloride, PXRD, Particle Size, Surface Area, TGA, DSC 
 
1. Introduction 
Zinc is a vital mineral element in human and animal 
nutrition with a wide array of biological activities. It plays an 
important role in catalytic, structural or regulation in greater 
than 200 zinc metalloenzymes identified in the biological 
systems [1, 2]. These enzymes are involved in the nucleic 
acid and protein metabolism as well as for the production of 
energy. Zinc also maintains the structural integrity of the 
biological membranes resulting in their protection against 
oxidative injury [1]. As a metallotherapeutic agent, zinc 
possesses various pharmacological activities include fertility 
enhancing, retino-protective, and putative antiviral activities 
[3]. Zinc is also used in the treatment of Wilson’s disease [4]. 
It also has the immunomodulatory and antioxidant activities 
[1]. Zinc is also used to prevent the development of several 
deficiency symptoms include parakeratosis, hypogeusia, 
anorexia, dysosmia, geophagia, hypogonadism, growth 
retardation, etc. [5-7]. Recently, it has been reported that zinc 
had increased the leukocyte count and phagocytic index, 
which potentiate the immunomodulatory effect along with 
Glycyrrhiza glabra [8]. Zinc chloride (ZnCl2) is hygroscopic 
inorganic salt and highly soluble in water [9]. It is sometimes 
used in pharmaceutical industry as drug and diagnostic agent 
due to its powerful astringent and mild antiseptic properties 
[10]. It is also used in mouth-wash and deodorant 
preparations. Zinc chloride is used in as dentin desensitizer 
i.e. reduces the sensitivity of the teeth to heat and cold. The 
other applications of zinc chloride include protein 
precipitation and insulin preparation [10, 11]. Literature 
reported that zinc chloride had been used in the treatment of 
cancer as a destructive agent [12] and the pluripotency 
maintenance of mouse embryonic stem cell through the 
regulation of STAT3 signaling pathway [13]. It can be useful 
for the palliative treatment of canine and malignant skin 
wounds [14]. It has opposite effect on the locomotor behavior 
of rats [15]. Therefore, zinc chloride was considered as one 
of the components in the novel proprietary herbomineral 
formulation for the source of zinc ion. This herbomineral 
formulation is designed as nutraceutical supplement, and can 
be used for the prevention and treatment of various human 
disorders. 
Every living organism preserves some kind of unique 
quality, an élan vital or vital force, which contributes the 
‘life’. From ancient-time this living force is known as prana 
by the Hindus, qi or chi by the Chinese, and ki by the 
Japanese and usually is believed to create the source of life 
that is related with soul, spirit, and mind. Now-a-days, this 
hypothetical vital force is considered as the Bioenergetics 
Field. This energy field is a dynamic electromagnetic field 
existing in the surround of the human body. The Biofield 
Energy is infinite and paradimensional. It can freely flow 
between the human and environment that leads to the 
continuous movement or matter of energy [16, 17]. Thus, the 
human can harness energy from the earth, the “universal 
energy field” and transmit it to any living or nonliving 
object(s) around the globe. The objects always receive the 
energy and respond in a useful way. This process is known as 
Biofield Energy Healing Treatment [18, 19]. Biofield 
(Putative Energy Fields) based Energy Therapies are used 
worldwide to promote health. The National Center of 
Complementary and Integrative Health (NCCIH) has been 
recognized and accepted Biofield Energy Healing as a 
complementary and alternative medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, 
movement therapy, pilates, rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki, cranial sacral therapy and applied prayer (as is 
common in all religions, like Christianity, Hinduism, 
Buddhism and Judaism) [20]. Biofield Energy Healing 
Treatment (The Trivedi Effect®) has been extensively studied 
with significant outcomes in many scientific fields such as 
cancer research [21]; altered antimicrobial sensitivity of 
pathogenic microbes in microbiology [22-24], biotechnology 
[25, 26], genetics [27, 28]; changing the structure of the atom 
in relation to various metals, ceramics, polymers and 
chemicals in materials science [29, 30], altered physical and 
chemical properties of pharmaceuticals [31, 32], 
nutraceuticals [33, 34], organic compounds [35-37], and 
improved overall growth and yield of plants in agricultural 
science [38, 39]. The physicochemical properties such as 
particle size, crystalline structure, crystallite size, surface 
area, etc. and thermal properties of a drug have a vital role in 
bioavailability as well as the stability of the drug during 
processing, formulation, storage, and packaging [40, 41]. 
Biofield Energy Treatment (The Trivedi Effect®) has been 
reported to change the particle size, specific surface area, 
crystalline nature, chemical and thermal behavior of an 
atom/ion through the possible mediation of neutrinos [42]. 
By considering all these aspects, powder X-ray diffraction 
(PXRD), particle size distribution analysis (PSD), Fourier 
transform infrared (FT-IR) spectrometry, ultraviolet-visible 
(UV-vis) spectroscopy, thermogravimetric analysis (TGA), 
and differential scanning calorimetry (DSC) analytical 
techniques were conducted in this study for the 
characterization of physical, structural, and thermal 
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properties of the Biofield Energy Treated and untreated zinc 
chloride. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Zinc chloride was procured from Tokyo Chemical Industry 
Co., Ltd. (TCI), Japan. All other chemicals used in the 
experiment were of analytical grade available in India. 
2.2. Biofield Energy Treatment Strategies 
Zinc chloride was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
parts, one part of the test compound was treated with The 
Trivedi Effect® - Energy of Consciousness Healing 
Treatment (Biofield Energy Treatment) by renowned Biofield 
Energy Healers and defined as Biofield Energy Treated zinc 
chloride, while the second part of the test compound did not 
receive any sort of treatment and defined as untreated or 
control zinc chloride sample. This Biofield Energy Treatment 
was provided by the group of eighteen renowned Biofield 
Energy Healers (The Trivedi Effect®), who participated in 
this study and performed the Biofield Energy Treatment 
remotely to the test compound. Eleven Biofield Energy 
Healers were remotely located in the U.S.A., four remotely 
located in Canada, one each of the Biofield Energy Healer 
remotely located in Ireland, United Kingdom, and Russia, 
performed the Biofield Energy Treatment remotely to the test 
compound, while the test compound was located in the 
research laboratory of GVK Biosciences Pvt. Ltd., 
Hyderabad, India. This Biofield Treatment was provided for 
5 minutes through Healer’s Unique Energy Transmission 
process remotely to the test compound under the laboratory 
conditions. None of the Biofield Energy Healers in this study 
visited the laboratory in person, nor had any contact with the 
compounds. Similarly, the control compound was subjected 
to “sham” healers for 5 minutes, under the same laboratory 
conditions. The sham healer did not have any knowledge 
about the Biofield Energy Treatment. After that, the Biofield 
Energy Treated and the untreated samples were kept in 
similar sealed conditions and were characterized thoroughly 
by PXRD, PSD, FT-IR, UV-visible spectroscopy, TGA, and 
DSC analysis. 
2.3. Characterization 
2.3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’pert Pro powder X-ray diffractometer system. A total of 
500.19 mg for the control and 500.23 mg for the Biofield 
Energy Treated samples were taken for the analysis. The X-
ray of wavelength 1.54056 Å was used. The data were 
collected in the form of a chart of the Bragg angle (2θ) vs. 
intensity, and a detailed table containing information on peak 
intensity counts, d value (Å), relative intensity (%), full-
width half maximum (FWHM) (θ°). From the XRD results, 
the crystallite size (G) was calculated using X’pert data 
collector and X’pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[43, 44]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following equation 1: 
G = kλ/(bCosθ)                             (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peak and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
the following equation 2: 
%	change	in	crystallite	size	 =
		
	
× 100  (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and 
taken the background measurement. After the background 
measurement, the sample was added to the sample unit with 
constant monitoring the obscuration and stopped the addition 
of sample when the obscuration reached in between 15% and 
20%. When the obscuration was stable, the measurement was 
taken twice, and the average was taken of two measurements. 
The average histogram of the two measurements was 
recorded. Along with histogram, the data will be presented in 
the table format which includes particle size (µm). Also, the 
values at below 10% level (d10), 50% level (d50), and 90% 
level (d90) were calculated from the histogram, and the 
calculations such as surface area (m2/g) were done by using 
software Mastersizer 2000. Percent change in particle size (d) 
for at below 10% level (d10), 50% level (d50), and 90% level 
(d90) was calculated using the following equation 3: 
%	change	in	particle	size =
##
#
× 100    (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) of 
the control and Biofield Energy Treated samples, 
respectively. 
The percent change in surface area (S) was calculated 
using the following equation 4: 
%	change	in	surface	area =
&	&	
&	
× 100   (4) 
Where, SControl and STreated are the surface area of the 
control and Biofield Energy Treated samples, respectively. 
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2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of zinc chloride was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
cm-1 by using pressed KBr disk technique. 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-vis spectroscopic analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1 cm quartz cell that has a slit width of 
1.0 nm. The wavelength ranges chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and absorbance maximum (λmax) were 
recorded. 
2.3.5. Thermogravimetric Analysis (TGA)/ Differential 
Thermogravimetric Analysis (DTG) 
The TGA analysis was performed using instruments TGA 
Q50 (TA instruments, USA) at a heating rate of 10ºC/min 
from room temperature, i.e. 30°C to 900°C under a nitrogen 
atmosphere (sample mass 16.0260 mg on a platinum pan). In 
TGA, the weight loss for each step was recorded in grams as 
well as in a percent loss with respect to the initial weight. 
Also, the onset, endset, and peak temperature for each step 
were recorded in TGA. In DTG, the onset, endset, peak 
temperature and integral area of the peak, change in heat 
(J/g) of each peak were recorded. Percent change in weight 
loss (W) was calculated using the following equation 5: 
%	change	in	weight	loss 
)	)	
)	
 100  (5) 
Where, WControl and WTreated are the weight loss of the 
control and Biofield Energy Treated samples, respectively. 
2.3.6. Differential Scanning Calorimetry (DSC)
 
The analysis was performed using the DSC Q20 (TA 
instruments, USA) differential scanning calorimeter. Sample 
quantity of 7.50 mg was weighed and sealed in aluminum 
pans and equilibrated at 25°C and heated up to 600°C at the 
heating rate of 10°C/min under nitrogen gas as purge 
atmosphere with a flow rate of 50 ml/min. The values of 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. The percent change in melting point (T) was 
calculated using the following equation 6: 
%	change	in	melting	point 
++
+
 100  (6) 
Where, TControl and TTreated are the melting point of the 
control and Biofield Energy Treated samples, respectively. 
The percent change in the latent heat of fusion (∆H) was 
calculated using the following equation 7: 
%	change	in	latent	heat	of	fusion 
,-.-
.-
 100  (7) 
Where, ∆HControl and ∆HTreated are the latent heat of fusion 
of the control and Biofield Energy Treated samples, 
respectively. 
3. Results and Discussion 
3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of both the control and Biofield 
Energy Treated samples of zinc chloride are shown in Figure 
1. The PXRD diffractogram of the control zinc chloride 
exhibited the intense peaks at Bragg’s angle (2θ) equal to 
15.87°, 16.82°, 25.68°, 29.58°, 35.19°, 38.50°, 48.91°, 
49.44°, 56.41°, 58.54°, and 72.36°. Similarly, the XRD 
diffractogram of the Biofield Energy Treated zinc chloride 
exhibited the intense peaks at 2θ equal to 15.87°, 16.82°, 
25.69°, 29.62°, 35.18°, 38.51°, 48.91°, 49.42°, 56.47°, 
57.68°, and 72.36°. The presence of sharp and intense peaks 
in the diffractograms revealed that both the samples of zinc 
chloride are crystalline in nature. The most intense peak was 
observed at 2θ equal to 49.44° in the control sample and 
48.91° in the Biofield Energy Treated sample (Figure 1). It 
was reported that the alternation in crystal morphology 
causes the alteration in the relative peak intensities [44]. 
 
Figure 1. Powder X-ray diffractograms of the control and Biofield Energy 
Treated zinc chloride. 
The average crystallite size was calculated using Scherrer 
equation [43]. The crystallite sizes of the Biofield Energy 
Treated sample were significantly altered in the range of -
49.96 to 50.02% compared with the control sample. The 
crystallite size of the Biofield Energy Treated zinc chloride at 
2θ equal to nearly 25.6°, 56.4°, 58.5°, and 72.3° (Table 1; 
entry 3, 9, 10, and 11) were significantly decreased in the 
range of 0.42% to 49.96% compared with the control sample. 
Consequently, the crystallite size of the Biofield Energy 
Treated zinc chloride at 2θ equal to 16.8°, 29.6, and 38.5, 
were increased in the range of 14.28% to 50.2% compared 
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with the control sample (Table 1; entry 2, 4, and 6). Overall, 
the crystallite size of the Biofield Energy Treated sodium 
selenate was decreased by 4.19% compared with the control 
sample (Table 1). It was reported that increased in lattice 
strain may reduce the crystallite size of the sample [45]. 
Therefore, it is hypothesized that Biofield Energy may induce 
some lattice strain within the treated molecules of zinc 
chloride. As a result, the grains were fractured into sub-
grains that could lead to decrease the crystallite size of the 
Biofield Energy Treated sample compared with the control 
sample. The study revealed that the Biofield Energy 
Treatment might be introduced a new polymorphic form of 
zinc chloride [46]. The decrease in crystallite size of the 
Biofield Energy Treated zinc chloride might increase its 
surface area and solubility compared with the control sample. 
Table 1. PXRD data for the control and Biofield Energy Treated zinc chloride. 
Entry 
No. 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated Control Treated Control Treated Control Treated % changea 
1 15.87 15.87 21.91 8.77 0.1004 0.1004 44.27 44.27 0.00 
2 16.82 16.82 34.48 21.62 0.2007 0.1338 22.17 33.26 50.02 
3 25.68 25.69 79.18 27.85 0.1171 0.1338 38.56 33.75 -12.47 
4 29.58 29.62 67.94 71.45 0.1338 0.1171 34.03 38.89 14.28 
5 35.19 35.18 40.91 42.54 0.1338 0.1338 34.52 34.52 0.00 
6 38.50 38.51 43.10 27.17 0.1673 0.1338 27.88 34.86 25.04 
7 48.91 48.91 58.81 100.00 0.1338 0.1338 36.16 36.16 0.00 
8 49.44 49.42 100.00 31.77 0.1004 0.1004 48.29 48.29 0.00 
9 56.41 56.47 16.78 9.30 0.1004 0.2007 49.78 24.91 -49.96 
10 58.54 57.68 24.25 10.22 0.1004 0.1004 50.30 50.09 -0.42 
11 72.36 72.36 12.51 7.83 0.1224 0.1632 44.61 33.46 -24.99 
12 Average crystallite size 39.14 37.50 -4.19 
FMHM: Full width at half maximum, a denotes the percentage in the crystallite size of the Biofield Energy Treated sample with respect to the control sample. 
3.2. Particle Size Distribution (PSD) Analysis 
Particle sizes (d10, d50, and d90) of the control and Biofield 
Energy Treated zinc chloride were investigated, and the 
results are presented in Table 2. The particle size at d10 and 
d50 values of the Biofield Energy Treated sample decreased 
by 4.72% and 2.70%, respectively compared with the control 
sample. But, the particle size of the Biofield Energy Treated 
sample increased at d90 by 0.83% compared with the control 
sample. The control sample showed a surface area of 3.11 
m2/g and it was increased to 3.21 m2/g in the Biofield Energy 
Treated zinc chloride (Table 2). Thus, the surface area of the 
Biofield Energy Treated sample was increased by 3.22% 
compared with the control sample. The results revealed that 
there might be an effect of high energy milling induced 
through the Biofield Energy Treatment to zinc chloride. 
Surface area has a major influence on the dissolution of a 
particle in a solvent. The reason that surface energy is the 
driving factor for dissolution efficiency and it is mainly 
influenced by the surface area and chemical affinity. The 
reduction in the particle size and increase in the surface area 
has a significant impact on the increase in dissolution, 
release, absorption, drug action, and dose uniformity of 
pharmaceuticals/nutraceuticals in various drug delivery 
system [47]. 
Table 2. Particle size data (d10, d50 and d90) and surface area of the control and Biofield Energy Treated zinc chloride. 
Test Item d10 (µm) d50 (µm) d90 (µm) Surface area (m
2/g) 
Zinc chloride (Control) 0.974 2.560 5.912 3.11 
Zinc chloride (Biofield Treated) 0.928 2.491 5.961 3.21 
Percent changea (%) -4.72 -2.70 0.83 3.22 
a denotes the percentage change in the particle size data (d10, d50, and d90) and surface area of the Biofield Energy Treated sample with respect to the control 
sample. 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of both the control and Biofield Energy 
Treated zinc chloride are presented in Figure 2. Zinc chloride 
is a tri-atomic molecule that shows SP hybridization with a 
bond angle of 180°, which is linear with four numbers of 
normal modes of vibration. The FT-IR spectra showed the O-
H stretching at 3900 cm-1 in both the control and Biofield 
Energy Treated samples [48]. The peak might be because of 
the hydrates of zinc chloride {ZnCl2(H2O)n where n = 1, 1.5, 
2.5, 3, and 4} [48]. The metal halides (i.e. Zn-Cl) show IR 
peak in the range of 750-100 cm-1 [49, 50]. The Zn-Cl 
stretching of the control and Biofield Energy Treated samples 
was found at 520 cm-1 and 521 cm-1, respectively. Overall, IR 
peaks of the Biofield Energy Treated zinc chloride did not 
show any significant structural changes with respect to the 
control sample. 
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Figure 2. FT-IR spectra of the control and Biofield Energy Treated zinc chloride. 
3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and Biofield 
Energy Treated zinc chloride are shown in Figure 3. The 
control and Biofield Energy Treated sample exhibited the 
wavelength of maximum absorbance (λmax) at 196.4 and 
196.2 nm, respectively. The peak at 196 nm was indicated a 
minor shift of absorbance maxima from 1.9793 (control) to 
1.9042 (the Biofield Energy Treated sample). It was reported 
that the UV absorbance occurred due to excitation of 
electrons from the highest energy occupied molecular orbital 
(HOMO) to the lowest energy unoccupied molecular orbital 
(LUMO) [32, 51]. However, the UV analysis of zinc chloride 
showed no change in the λmax of the Biofield Energy Treated 
sample compared with the control sample. It indicated that 
energy gap between the HOMO and LUMO in the Biofield 
Energy Treated zinc chloride was comparatively similar to 
that of the control sample. 
 
Figure 3. UV-Vis spectra of the control and Biofield Energy Treated zinc chloride. 
3.5. Thermogravimetric Analysis (TGA)/ Differential 
Thermogravimetric Analysis (DTG) 
The TGA and DTG thermograms of the control and 
Biofield Energy Treated samples are shown in Figures 4 and 
5 respectively, which showed two steps of the thermal 
degradation process (Table 3). The TGA thermograms 
revealed that the weight loss of the Biofield Energy Treated 
sample was significantly reduced by 22.54% in the 1st step of 
degradation compared with the control sample. Unlikely, the 
weight loss of the Biofield Energy Treated sample was 
slightly increased by 0.64% in the 2st step of degradation 
compared with the control sample. The pattern of thermal 
degradation of the control zinc chloride was nearly matched 
with the reported data [52]. The control and Biofield Energy 
Treated samples had lost their weight by 98.63% and 
98.13%, respectively from their total original weight during 
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the process. The total weight loss was decreased in the 
Biofield Energy Treated zinc chloride by 0.51% compared 
with the control sample. The DTG thermograms (Figure 5) 
exhibited two peaks in both the samples. The DTG 
thermograms of the control and Biofield Energy Treated 
samples disclosed the maximum temperature (Tmax) at 
505.60°C and 501.24°C, respectively. The DTG analysis 
indicated that the decomposition temperature of the Biofield 
Energy Treated zinc chloride was slightly lower (0.86%) than 
the control sample. 
The overall results concluded that the thermal stability of 
the Biofield Energy Treated zinc chloride was increased 
compared with the control sample. The improvement in the 
thermal stability would be the advantage in the long term 
storage stability and shelf-life of the 
nutraceutical/pharmaceutical products [53]. 
 
Figure 4. The TGA thermograms of control and Biofield Energy Treated zinc chloride. 
Table 3. Thermal degradation data of the control and Biofield Energy Treated zinc chloride. 
S. No. 
Temperature (oC) % Weight loss 
% Changea 
Control Treated Control Treated 
1st step of degradation 318.93 315.49 4.88 3.78 -22.54 
2nd step of degradation 895.18 895.18 93.75 94.35 0.64 
Total weight loss - - 98.63 98.13 -0.51 
a denotes the percentage change in the weight loss of the Biofield Energy Treated sample with respect to the control sample. 
 
Figure 5. DTG thermograms of the control and Biofield Energy Treated zinc chloride. 
3.6. Differential Scanning Calorimetry (DSC) Analysis 
Measurement of the decomposition temperature and 
enthalpy of decomposition of the control and Biofield Energy 
Treated samples of zinc chloride was performed using DSC 
analysis, and the results are presented in Figure 6 and Table 
4. The DSC thermograms of the control and Biofield Energy 
Treated samples represented the sharp exothermic peak in 
both the samples. The enthalpy of decomposition (∆H) was 
increased by 34.9% in the Biofield Energy Treated sample 
(66.10 J/g) compared with the control sample (89.17 J/g). A 
slight lowering decomposition temperature by 2.12% was 
observed in the Biofield Energy Treated zinc chloride 
(439.81°C) compared with the control sample (449.32°C). 
The results suggested it can be hypothesized that the Biofield 
Energy Treatment might cause some alteration in kinetic 
energy of the Biofield Energy Treated sample compared with 
the control. Thus, the Biofield Energy Treated zinc chloride 
needs more energy in the form of enthalpy of decomposition 
to undergo the process of decomposition compared with the 
control sample. The intermolecular force possibly increased 
the enthalpy of decomposition due to the Biofield Energy 
Treatment. The enhanced thermal stability of a drug is an 
advantage in the maintenance of the product in long term 
storage condition throughout the shelf-life for any 
pharmaceutical formulations [54]. 
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Table 4. The enthalpy of decomposition (J/G) and degradation temperature (°C) of the control and Biofield Energy Treated zinc chloride. 
Sample 
Enthalpy of decomposition 
(∆H) J/g 
Onset decomposition 
temperature (Tonset)°C 
Peak decomposition 
temperature (Tpeak)°C 
Endset decomposition 
temperature (Tendset)°C 
Control 66.10 443.07 449.32 452.86 
Biofield Energy Treated 89.17 433.29 439.81 442.56 
% Changea 34.90 -2.21 -2.12 -2.27 
Tonset:
 Onset melting temperature, Tpeak: Peak decomposition temperature, Tendset: Endset decomposition temperature, ∆H: Enthalpy of decomposition, 
a denotes 
the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
 
Figure 6. DSC thermograms of the control and Biofield Energy Treated zinc chloride. 
4. Conclusions 
The current study revealed that the Consciousness Energy 
Healing Treatment (The Trivedi Effect®) had the notable 
effects on the physicochemical and thermal properties of zinc 
chloride. A significant change of the crystallite size and 
relative intensities of the PXRD peaks was observed in the 
treated sample compared with the control sample. The 
crystallite sizes of the treated sample were significantly 
altered in the range of -49.96% to 50.02% compared with the 
control sample. The crystallite size of the treated sample was 
decreased by 4.19% compared with the control sample. The 
particle size values of the Biofield Energy Treated sample at 
d10 and d50 were decreased by 4.72% and 2.70%, respectively 
whereas, at d90 it was increased by 0.83% compared with the 
control sample. Consequently, the surface area was increased 
by 3.22% in the treated sample compared with the control 
sample. The FT-IR spectroscopic analysis revealed that Zn-
Cl stretching in the control and treated sample was at 520 cm-
1 and 521 cm-1, respectively. The UV-vis analysis exhibited 
that the wavelength of the maximum absorbance (λmax) of the 
control and treated samples was at 196.4 and 196.2 nm, 
respectively. The TGA thermograms revealed two steps of 
thermal degradation and the weight loss of the treated sample 
was significantly reduced by 22.54% in the 1st step of 
degradation compared with the control sample. The DSC 
analysis showed that the enthalpy of decomposition was 
significantly increased by 34.9% in the treated sample (∆H = 
89.17 J/g) compared with the control sample (∆H = 66.10 
J/g). Overall, DSC and TGA analysis indicated that the 
thermal stability of the treated sample was increased 
compared with the control sample. The current study 
anticipated that The Trivedi Effect®-Energy of Consciousness 
Healing Treatment might lead to generate a new polymorphic 
form of zinc chloride, which would be more soluble, stable, 
and higher absorption rate compared with the control sample. 
Hence, the treated zinc chloride could be very useful to 
design the various forms of nutraceuticals and/or 
pharmaceutical formulation that might offer a better 
therapeutic response against inflammatory diseases, 
immunological disorders, aging, stress, Wilson’s disease, 
viral diseases, parakeratosis, hypogeusia, anorexia, dysosmia, 
geophagia, hypogonadism, growth retardation, etc. 
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